See the embryonic expression pattern of Akt1 at the Berkeley Drosophila Genome Project Patterns of Gene Expression Site
The temporal and spatial expression of the DRAC-PK/Akt1 transcripts during development has been examined. For Northern blot analysis two probes were used: the cDNA DRAC 7 and a probe from the 3`-untranslated region located between the first polyadenylation signal (nucleotides 4374-4379) and a polyadenylation signal at nucleotides 5013-5018 in the DRAC-PK genomic sequence. Whereas DRAC 7 recognizes all classes of transcripts, the 3'-end probe would detect only those that use the second polyadenylation signal. Northern analysis of total RNA isolated from staged collections of embryos and larvae and from adult female flies using DRAC 7 as a probe revealed the presence of two major transcripts of 2.7 and 3.9 kb. The 2.7-kb transcript is expressed at high levels in 0-3-h embryos and is also expressed in adult females, indicating that this is a maternally regulated mRNA. The 3.9-kb transcript is expressed throughout embryogenesis and larval stages and is also detected in early and late pupal stages. This transcript is also expressed in the adult female flies, indicating both maternal and zygotic regulation of gene expression. When the 3'-probe was used, only the larger transcript could be detected, suggesting that the 2.7-kb transcript is generated by use of the first polyadenylation signal. This indicates that the cDNA SDE-RAC 109 is derived from the 2.7-kb maternal transcript (Andjelkovic, 1995).
In situ hybridization to whole-mount embryos and dissected ovaries, using DRAC 7 as a probe, demonstrates that maternally provided DRAC-PK transcripts are synthesized in the nurse cells of the ovaries. During oocyte maturation there is no apparent localization of the mRNA. No variation in expression could be detected throughout embryogenesis. Before cellularization, after cellularization, and throughout gastrulation, germ band extension, and retraction, DRAC-PK/Akt1 transcripts remain uniformly distributed and are expressed at a high level (Andjelkovic, 1995).
Northern analysis demonstrates that the DRAC-PK gene expression is both maternally and zygotically regulated. Also Western blot analysis reveals differences in DRAC-PK protein forms and abundance between embryos and adult flies. The expression of the DRAC-PK gene protein products during the Drosophila life cycle was examined. The major form detected throughout development is DRAC-PK66. The highest level of expression (arbitrarily taken as 100%) is found in 0-3-h embryos and subsequently declines to 60% during late embryogenesis. A further decline in DRAC-PK66 levels is observed during larval development (20% in the third instar larvae), followed by a sharp increase in the early pupae (80%). The protein levels are 30% in adult flies. DRAC-PK85 follows the expression of DRAC-PK66, except in the three larval stages where it could not be detected. There is no difference in the expression of DRAC-PK66 and -85 between female and male flies. p120 is detected during embryogenesis, where its expression follows the pattern of DRAC-PK66 and -85. It is found to be significantly higher in early than in late pupae, which is not the case with DRAC-PK66 and -85. These results suggest the involvement of DRAC-PK and the p120 protein in embryogenesis, as well as postembryonically. The spatial expression of the DRAC-PK proteins during embryogenesis was analyzed using the affinity-purified antirecombinant antibody No. 36. Proteins are uniformly distributed in all embryonic stages, which is in good correlation with the transcript localization. Also, during the syncytial blastoderm stage, specific staining is detected in the cytoplasm surrounding dividing nuclei and is always excluded from the chromatin (Andjelkovic, 1995).
The insulin/insulin-like growth factor signalling (IIS) cascade performs a broad range of evolutionarily conserved functions, including the regulation of growth, developmental timing and lifespan, and the control of sugar, protein and lipid metabolism. Recently, these functions have been genetically dissected in Drosophila, revealing a crucial role for cell-surface activation of the downstream effector kinase Akt in many of these processes. However, the mechanisms regulating lipid metabolism and the storage of lipid during development are less well characterized. The nutrient-storing nurse cells of the fly ovary were used to study the cellular effects of intracellular IIS components on lipid accumulation. These cells normally store lipid in a perinuclear pool of small neutral triglyceride-containing droplets. Loss of the IIS signalling antagonist PTEN, which stimulates cell growth in most developing tissues, produces a very different phenotype in nurse cells, inducing formation of highly enlarged lipid droplets. Furthermore, the accumulation of activated Akt in the cytoplasm is responsible for this phenotype and leads to a much higher expression of LSD2, the fly homologue of the vertebrate lipid-storage protein perilipin. This work therefore reveals a signalling mechanism by which the effect of insulin on lipid metabolism could be regulated independently of some of its other functions during development and adulthood. It is speculated that this mechanism could be important in explaining the well-established link between obesity and insulin resistance that is observed in Type 2 diabetes (Vereshchagina, 2006).
These data suggest that the effect of cytoplasmic P-Akt on lipid storage may be cell type-specific. Increasing IIS throughout the whole organism in viable Pten mutants surprisingly reduces total lipid content, whereas decreasing IIS elevates lipid levels both in flies and mice. It has not been possible to show biochemically whether triglycerides are increased rather than merely redistributed in Pten mutant ovaries, because only a small minority of the nurse cells is mutant. However, in some late-stage clones, in which cytoplasmic volumes are decreasing, lipid levels often appear elevated in mutant cells. Insulin-stimulated increases in lipid-droplet number and size have been observed in mammals, and, interestingly, when tumours are induced in mouse liver by raising IIS, lipid-storage mechanisms are also activated. It is proposed that these cell type-specific responses are due to selective accumulation of an IIS-modulated, cytoplasmic activated Akt pool that must, to some extent, be controlled independently of cell-surface P-Akt. Indeed, a Drosophila phosphatase has been identified that regulates levels of cytoplasmic P-Akt in nurse cells, and it has been shown that mutations in this gene produce a very similar enlarged lipid-droplet phenotype, confirming this hypothesis (Vereshchagina, 2006).
How could elevated cytoplasmic P-Akt induce such a dramatic lipid-droplet phenotype in nurse cells? In mammals, Akt can promote the transcription of genes involved in lipid biosynthesis and storage pathways. The data indicate LSD2/perilipin is one of these targets. IIS also post-translationally upregulates the activity of mammalian perilipin. Interestingly, ovaries mutant for Lsd2 show altered lipid accumulation, but droplets are still formed. Therefore, LSD2 is almost certainly one, but not the only, target for IIS in the control of lipid-droplet accumulation in nurse cells. In this context, it is interesting to note that, in addition to its proposed role in coating lipid droplets, LSD2 has recently been shown to regulate microtubule-dependent trafficking of these organelles. Since cytoplasmic P-Akt could still be associated with intracellular membranes or the droplet surface, it may be well positioned to modulate this transport process (Vereshchagina, 2006).
Obesity is a well-established predisposing factor in the acquisition of cellular insulin resistance and Type 2 diabetes. Increased levels of circulating free fatty acids (FFAs) associated with obesity appear to be important in this link. However, it is unclear whether other mechanisms are also involved or how reduced insulin sensitivity ultimately impacts on lipid storage. Molecules downstream of Akt are known to regulate cell-surface IIS through at least two negative-feedback loops involving downstream S6 kinase and the transcription factor FOXO. This work therefore raises the possibility that any predisposition towards increased cytoplasmic P-Akt could specifically promote lipid storage and also selectively suppress insulin-dependent events at the cell surface. It will be interesting to investigate further the molecules involved in controlling this P-Akt pool and whether the feedback mechanisms have any role to play in linking obesity and insulin resistance in Type 2 diabetes (Vereshchagina, 2006).
The decision between survival and death is an important aspect of cellular regulation during development and malignancy. Central to this regulation is the process of apoptosis, which is conserved in multicellular organisms. A variety of signaling cascades have been implicated in the modulation of apoptosis, including the phosphatidylinositol (Pl) 3-kinase pathway. Activation of Pl 3-kinase is protective, and inhibition of this lipid kinase enhances cell death under several conditions, including deregulated expression of c-Myc, neurotrophin withdrawal and anoikis. Recently, the protective effects of Pl 3-kinase have been linked to its activation of the pleckstrin homology (PH)-domain-containing protein kinase B (PKB or AKT). PKB/AKT was identified from an oncogene, v-akt, found in a rodent T-cell lymphoma. To initiate a genetic analysis of PKB, a Drosophila PKB/AKT mutant (termed Dakt1) was isolated and characterized. It exhibits ectopic apoptosis during embryogenesis as judged by induction of membrane blebbing, DNA fragmentation and macrophage infiltration. These data implicate Dakt1 as a cell survival gene in Drosophila, consistent with cell protection studies in mammals (Staveley, 1998).
A single amino-acid change, F327I, was found to be a kinase dead mutant form of Akt1. This phenylalanine (F) residue is a core residue in subdomain VII of the kinase catalytic domain, forming the 'DFG' motif which is highly conserved among protein kinases including mammalian PKB proteins. Since Dakt1 is a maternally expressed gene, the maternal contribution of Dakt1 was tested using germline clone (GLC) analysis. GLC q females, containing clones of cells bearing the F327I mutation, produce embryos that lack various portions of larval cuticle by the end of embryogenesis. The range of phenotypes depends on the level of zygotic Dakt1 activity in the embryo. Without any zygotic expression of Dakt1, q GLC embryos produce only a few scraps of cuticle. When q GLC embryos express some zygotic Dakt1, some ventral cuticle is produced. This phenotype is extensively suppressed by expression of Dakt1 using a heat-shock inducible hs-Dakt1 transgene. Since mammalian PKB/AKT has been implicated in anti-apoptotic activity, a test was performed of Dakt1 GLC embryos for evidence of apoptosis. Acridine orange (AO) staining has been shown to be a good indicator of apoptosis (and not necrosis) in Drosophila, detecting cellular events such as membrane blebbing. AO staining of Dakt1 GLC embryos shows extensive apoptosis compared to wild-type embryos. Confirmation of an effect on apoptosis was performed using a TUNEL assay in Dakt1 embryos to detect the incidence of DNA fragmentation. Dakt1 embryos shows extensive DNA breakage as assayed by TUNEL in situ. Incidence of TUNEL signal in Dakt1 GLC embryos precedes the initiation of the signal in wild-type embryos. TUNEL signal accumulates during development of Dakt1 embryos to engulf the majority of the embryo. During apoptosis, macrophages converge to engulf cellular fragments by phagocytosis. Antibody to Croquemort (Crq), the Drosophila homolog of CD36, was used to detect macrophages in embryos. Dakt1 embryos exhibit a significant increase in Crq expression, as compared to wild-type embryos. This expression is at the cell surface and focuses on the apoptotic cells. It appears, therefore, that loss of Dakt1 activity results in premature and ectopic apoptosis with the characteristics of membrane blebbing, DNA fragmentation and macrophage-mediated endocytosis (Staveley, 1998).
The deficiency of the reaper (rpr), grim and hid genes [Df(3L)H99] blocks apoptosis in Drosophila. Overexpression of any of these three genes results in ectopic apoptosis in embryos. It was therefore of interest to see whether Dakt1 mutants result in apoptosis through the mis-expression of rpr, grim or hid. This was found not to be the case, since Dakt1 mutant embryos do not show overexpression of these genes. Loss of rpr, grim and hid in H99 do not suppress the phenotype of Dakt1 GLC embryos. These results suggest that Dakt1 and H99 modulate apoptosis via distinct mechanisms. To test the involvement of caspases in Dakt1-mediated apoptosis, the baculoviral caspase-inhibitory protein p35 was expressed in Dakt1 embryos. Ectopic p35 has been shown to block caspase activity and suppress apoptosis in Dakt1 embryos, and hs-p35 effectively blocks apoptosis in Dakt1 embryos, demonstrating the requirement for caspase activity in this process (Staveley, 1998).
These epistasis tests suggest that Dakt1 does not function upstream of the rpr, grim and hid gene functions in the embryo. It is possible, though, that Dakt1 might be regulated by the rpr, grim and hid genes (at the H99 locus) and in fact act downstream of these genes. This presents two possibilities: (1) Dakt1 and the H99 locus represent independent pathways; (2) the H99 locus might repress Dakt1 function. This study thus provides the first genetic evidence implicating PKB as an anti-apoptotic factor (Staveley, 1998).
To determine whether Akt1 transduces growth-related signals, Akt1-deficient somatic clones were generated in the developing eye by mitotic recombination. Adult eyes exhibit a reduction in size in Akt1-deficient rhabdomeres, which, in some instances, co-exist with normal-sized heterozygous cells in the same ommatidium. Akt1 mutant clones are rare and small and are obtained only after heat-shock during the third instar larval stage. These observations indicate that the lack of Akt1 clones in the adult retina following induction at early larval stages may have resulted from cell competition, by which the Akt1-deficient cells would be eliminated and replaced by the surrounding wild-type sister cells. The phenotype of the Akt1-deficient rhabdomeres may have resulted from perturbations of cell growth or proliferation. The smaller size of these rhabdomeres shows that Akt1 is essential for normal cell growth, but dispensable for cell-fate determination. Moreover, the co-existence of Akt1 mutant rhabdomeres with wild-type twin-spot rhabdomeres in the same ommatidium suggests a cell-autonomous control of cell growth by Akt1 (Verdu, 1999).
The small size of the clones of Akt1-deficient cells could be the result of an impairment in the proliferation, survival, or both, of homozygous null cells. To evaluate more specifically the effects of Akt1 on proliferation or growth in vivo, upstream activation sequence (UAS)-Akt1 lines were generated with which to investigate the effects of altering the amount of Akt1 during Drosophila eye and wing imaginal disc development. The gmrGAL4 transgene targets expression of Akt1 to cells posterior to the morphogenetic furrow, producing flies exhibiting enlarged and bulging eyes with a mild disruption of the regular, external lattice. Similar, but less pronounced, effects are observed with a sevGAL4 transgene. Quantitative analysis reveals that the Akt1-induced increase in the size of the eye is caused by an increase in the size but not in the number of ommatidia. To determine the extent of this phenotype, tangential sections of these eyes were examined. In spite of the rough appearance of the adult compound eye, Akt1 expression does not affect the normal process of photoreceptor cell-fate determination in these larger ommatidia (Verdu, 1999).
Akt plays a central part in promoting the survival of a wide range of cell types in mammalian systems and in Drosophila embryos. However, overexpression of Akt1 does not alter the normal rate of apoptosis in the eye, as shown by equivalent acridine orange staining in control and gmrGAL4/UAS-Akt1 eye imaginal discs. Hence, overexpression of Akt1 affects neither the normal processes of cell-fate determination nor apoptosis in the developing retina (Verdu, 1999).
Pten, a Drosophila homolog of the mammalian PTEN tumor suppressor gene, plays an essential role in the control of cell size, cell number, and organ size. In mosaic animals, Pten minus cells proliferate faster than their heterozygous siblings, show an autonomous increase in cell size, and form organs of increased size, whereas overexpression of Pten results in opposite phenotypes. The loss-of-function phenotypes of Pten are suppressed by mutations in the PI3K target Dakt1 and the translational initiation factor eif4A, suggesting that Pten acts through the PI3K signaling pathway to regulate translation. Although activation of PI3K and Akt has been reported to increase rates of cellular growth but not proliferation, loss of Pten stimulates both of these processes, suggesting that PTEN regulates overall growth through PI3K/Akt-dependent and -independent pathways. Furthermore, Pten does not play a major role in cell survival during Drosophila development. These results provide a potential explanation for the high frequency of PTEN mutation in human cancer (Gao, 2000).
Previous studies have shown that loss of PTEN function promotes cell survival in mammals through activation of Akt. In addition, PTEN acts through Akt in metabolic and longevity control in C. elegans. Dakt1, a Drosophila homolog of Akt, has been suggested to play a role in cell survival in embryogenesis (Staveley, 1998) and cell size control (Verdu, 1999). A hypomorphic allele of Dakt1 has been identified in the large-scale gene disruption project carried out by the Berkeley Drosophila Genome Project. This allele is semilethal, and homozygous survivors show reduced body size and cell size, consistent with a role of Dakt1 in growth control. To examine whether Pten controls cell size through regulating Akt activity, Pten mutant clones were generated in Dakt1 mutant animals. Dakt1 mutation completely suppressed the increase of cell size associated with the Pten mutation. This result provides strong in vivo evidence that Dakt1 functions downstream of (or in parallel to) Pten in the control of cell size. Taken together, these genetic interactions suggest that the role of Pten in opposing signaling through the PI3K/Akt pathway is conserved between flies and vertebrates (Gao, 2000).
A mutation has been isolated in the Drosophila homolog of TSC1 (Tsc1). Cells mutant for Tsc1 are dramatically increased in size yet differentiate normally. Organ size is also increased in tissues that contain a majority of mutant cells. Clones of Tsc1 mutant cells in the imaginal discs undergo additional divisions but retain normal ploidy. Flow cytometry analysis indicates that the increase in cell size is not due to endoreplication. Tsc1 protein is shown to bind to Drosophila Tsc2 in vitro. Overexpression of Tsc1 or Tsc2 alone in the wing and eye has no effect, but co-overexpression leads to a decrease in cell size, cell number, and organ size. Genetic epistasis data are consistent with a model that Tsc1 and Tsc2 function together in the insulin signaling pathway (Potter, 2001).
Recent work has demonstrated that the insulin signaling pathway plays an important role in the regulation of cell size, cell number, and organ size. Mutations of Drosophila PTEN (dPTEN), which functions as a negative regulator of insulin signaling, result in phenotypes that resemble the effects of Tsc1 and Tsc2 mutations. Therefore, genetic epistasis experiments were performed to test whether Tsc1 or Tsc2 might also function to negatively regulate insulin signaling. Overexpression of Drosophila insulin receptor (dinr) using the eyGAL4 driver leads to lethality at 25°C and a dramatic increase in ommatidia number in escapers at room temperature. Co-overexpression of Tsc1 and Tsc2 (but not either Tsc1 or Tsc2 alone) rescues both the lethality and the extra ommatidia phenotype caused by dinr overexpression. Furthermore, overexpression of dinr using the pGMR-GAL4 driver leads to an increase in ommatidium size, which is also suppressed by co-overexpression of Tsc1 and Tsc2. Clones of dinr mutant ommatidia are smaller in size than wild-type. Ommatidia that are mutant for both dinr and Tsc1, however, exhibit the Tsc1 mutant phenotype of increased ommatidium size (Potter, 2001).
Overexpression of dPTEN using the pGMR-GAL4 driver leads to eyes with a decreased ommatidium size. However, overexpression of dPTEN is unable to suppress the clonal Tsc1 mutant phenotype. Similar to dinr, clones of dAkt mutant ommatidia are smaller in size. Ommatidia mutant for both dAkt and Tsc1 display the Tsc1 phenotype. Similarly, ommatidia that contained Tsc2 mutant clones in a dAkt mutant background exhibit the Tsc2 mutant phenotype. These results suggest that in the eye, Tsc1 and Tsc2 function genetically epistatic to (downstream of) dinr, dPTEN, and dAkt (Potter, 2001).
Genetic analyses suggest that the TSC genes act in a parallel pathway that converges on the insulin pathway downstream from Akt. The most convincing evidence for a functional link between the TSC genes and insulin signaling comes from the observation that heterozygosity of TSC1 or TSC2 is sufficient to rescue the lethality of loss-of-function InR mutants. This argues that the TSC genes are intimately linked to insulin signaling, rather than functioning in a totally independent cell-growth pathway. These results suggest that the TSC tumor suppressor genes are novel negative regulators of insulin signaling, and modulating the activities of the TSC genes might provide a potential way to correct insulin signaling defects in certain diseases such as diabetes and obesity (Gao, 2001).
Previous studies have shown that loss of inr or Akt leads to decreased cell size. To investigate the relationship between inr, Akt, and the TSC genes, TSC1;Akt and TSC1;inr double-mutant clones were studied. Cells homozygous for a strong allele of inr, or a null allele of Akt are smaller, and are rarely recovered in adult eye clones because of cell competition during development. However, TSC1;inror TSC1;Akt1 double-mutant cells showed a similar cell size increase as that observed in TSC1- cells. Furthermore, the competitive disadvantage of inr and Akt mutant cells is also rescued in the TSC1;inr or TSC1;Akt1 double-mutant clones, resulting in larger clones that contained more cells. This result suggests that TSC1 acts genetically downstream from Akt. This observation is compatible with either TSC1 acting molecularly downstream from Akt in the linear InR-PI3K-Akt pathway, or TSC1 acting in a parallel pathway that converges on the insulin pathway downstream from Akt (Gao, 2001).
The Drosophila gene chico encodes an insulin receptor substrate that functions in an insulin/insulin-like growth factor (IGF) signaling pathway. In the nematode C. elegans, insulin/IGF signaling regulates adult longevity. Mutation of chico extends fruit fly median life-span by up to 48% in homozygotes and 36% in heterozygotes. Extension of life-span is not a result of impaired oogenesis in chico females, nor is it consistently correlated with increased stress resistance. The dwarf phenotype of chico homozygotes was also unnecessary for extension of life-span. The role of insulin/IGF signaling in regulating animal aging is therefore evolutionarily conserved (Clancy, 2001).
In Drosophila, the insulin/IGF receptor INR, the insulin receptor substrate Chico, the phosphatidylinositol 3-kinase (PI3K) Dp110/p60, and the PI3K target protein kinase B (PKB, also known as DAkt1) form a signaling pathway that regulates growth and size. The effects on aging of hypomorphic mutations in Inr (equivalent to daf-2) and PKB, and null mutations in chico and the catalytic (Dp110, equivalent to age-1) and adapter (p60) PI3K subunits were examined. All mutants were tested as heterozygotes. chico1 and PKB3 homozygotes and InrGC25/InrE19 transheterozygotes, which form viable dwarf adults, were also examined. The remaining mutations were homozygous lethal (Clancy, 2001).
Most mutants tested had normal or significantly decreased life-span. For example, PKB3 homozygotes and InrGC25/InrE19 flies are short-lived. By contrast, chico1 extends life-span. Homozygous chico1 females exhibit an increase of median and maximum life-span of up to 48% and 41%, respectively. chico1 heterozygotes also exhibit increases in median life-span of up to 36% and 13% in females and males, respectively. Homozygous males, however, are slightly short-lived (Clancy, 2001).
Of the mutations tested, only chico1 increases life-span. This may be because the effect of reduced IIS on life-span depends on the degree to which signaling is reduced. Unlike the other null mutations in IIS genes tested, chico1 is not homozygous lethal, presumably because the INR receptor can signal to PI3K directly, as well as indirectly via Chico. Thus, chico1 mutants may be long-lived because of the relatively mild reduction in pathway activity that they bring about. Notably, severe IIS mutations in C. elegans can cause premature mortality in some adults, although the maximum life-span of populations is invariably increased. This is probably why InrGC25/InrE19 flies are short-lived: Demographic analysis indicates that a reduction in the age-specific mortality rate acceleration occurs, whose effect on survival is masked by an elevated rate of age-independent mortality. Furthermore, a different heteroallelic Drosophila Inr mutant to that tested here exhibits an 85% increase in female life-span. By contrast, in short-lived PKB3 populations, no reduction in mortality rate acceleration is seen. This raises the possibility that a second pathway downstream of chico might regulate aging in Drosophila. Interestingly, Chico contains potential binding sites for the Drk/Grb2 docking protein, consistent with signaling via Ras/mitogen-activated protein kinase (Clancy, 2001).
Analysis of Drosophila Foxo indicates that it is a critical PKB target, but that it mediates only one aspect of PKB function. Several lines of evidence support this model. (1) The effects of ectopic overexpression of Foxo and the human homolog hFOXO3a in the developing Drosophila eye are altered by Dp110 and PKB signaling as well as by nutrient levels. Under conditions of lowered insulin signaling, the phenotypes resulting from expression of foxo and hFOXO3a are dramatically enhanced. This situation was mimicked by expressing a PKB-insensitive phosphorylation mutant, suggesting that endogenous PKB signaling is required to mitigate the effects of ectopically expressed Foxo and hFOXO3a. (2) The physiological relevance of Foxo in PKB signaling is most vividly demonstrated by the observation that the larval lethality associated with the complete loss of PKB is rescued by foxo mutations to the extent that some flies develop to pharate adults. The lethality associated with loss of PKB function is therefore to a large extent due to the hyperactivation of Foxo. (3) Loss of Foxo function suppresses the effects of insulin-signaling mutations only partially; Foxo mediates a reduction in cell number but not in cell size in response to reduced insulin signaling (Jünger, 2003).
Genetic analysis of the control of body size in Drosophila has revealed two classes of mutations. Flies carrying mutations in chico or viable allelic combinations of Inr, Dp110, and PKB are reduced in body size by up to 50% owing to a reduction in both cell size and cell number. Conversely, flies mutant for S6K exhibit a more moderate reduction in body size, caused almost exclusively by a reduction in cell size. This suggests that the pathways controlling cell number and cell size bifurcate at or below PKB. Although foxo single mutants have no obvious size phenotype, loss of foxo substantially suppresses the cell-number reduction observed in insulin-signaling mutants. It appears that Foxo mediates the repression of proliferation in flies mutant for Inr, chico, Dp110, and PKB without being required for the reduction in cell size. Chico-Foxo double mutant flies even have slightly smaller cells than chico mutants, suggesting that removal of Foxo permits cell-cycle acceleration under conditions of impaired insulin signaling. The pathway controlling body size in response to insulin therefore bifurcates at the level of PKB: PKB controls cell number by inhibiting Foxo function and PKB controls cell size, at least under some conditions, by regulating S6K activity by phosphorylation of TSC2 (Jünger, 2003).
The signaling systems controlling cell size and cell number are tightly interconnected. Genetic and biochemical analyses have revealed five different links between the TSC-TOR-S6K pathway and the Inr-PKB-Foxo pathway. (1) Under conditions of unnaturally high insulin-signaling activity (that is, following the oncogenic activation of PKB) PKB phosphorylates and inactivates TSC2, resulting in increased activation of S6K. Under normal culture conditions this regulation does not seem critical, however, loss of dPKB function does not lower dS6K activity in larval extracts. (2) Under physiological conditions, PDK1 regulates PKB as well as S6K. (3) S6K itself downregulates dPKB activity in a negative feedback loop. (4) Under severe starvation conditions, nuclear Foxo presumably activates target genes that reduce cell proliferation. One of these target genes is 4E-BP, which encodes an inhibitor of translation initiation. When conditions improve, the insulin and TOR signaling pathways can stimulate translation by disrupting the 4E-BP/eIF4E complex via phosphorylation of 4E-BP, and in parallel by repressing FOXO-dependent 4E-BP expression. (5) Under even more severe starvation or stress conditions, full activation of Foxo upregulates expression of the insulin receptor itself, thus rendering the cell hypersensitive to low insulin levels. These multiple positive and negative interactions ensure a continuous fine adjustment of the growth rate to changing environmental conditions (Jünger, 2003).
Diverse extrinsic and intrinsic cues must be integrated within a developing organism to ensure appropriate growth at the cellular and organismal level. In Drosopohila, the insulin receptor/TOR/S6K signaling network plays a fundamental role in the control of metabolism and cell growth. scylla and charybdis (a. k. a. charybde), two homologous genes identified as growth suppressors in an EP (enhancer/promoter) overexpression screen, act as negative regulators of growth. The genes are named after mythological monsters that lived in the Strait of Messina between Sicily and Italy, posing a threat to the passage of ships. The simultaneous loss of both genes generates flies that are more susceptible to reduced oxygen concentrations (hypoxia) and that show mild overgrowth phenotypes. Conversely, either scylla or charybdis overactivation reduces growth. Growth inhibition is associated with a reduction in S6K but not PKB/Akt activity. Together, genetic and biochemical analysis places Scylla/Charybdis downstream of PKB and upstream of TSC1. Furthermore, scylla and charybdis are induced under hypoxic conditions and scylla is a target of Drosopohila HIF-1 (hypoxia-inducible factor-1: Similar) like its mammalian counterpart RTP801/REDD1, thus establishing a potential cross-talk between growth and oxygen sensing (Reiling, 2004).
Although loss of Scylla function does not produce a mutant phenotype on its own, whether it would alter the PKB/PDK1 overexpression eye phenotype was tested. Indeed, loss of Scylla function enhances the PKB/PDK1 overgrowth phenotype. Thus, Scylla is essential for attenuating the increased growth in response to hyperactivation of the Inr pathway. Furthermore, loss of Scylla partially suppresses the growth reduction associated with reduced PKB function as assessed by comparing weights of PKB3 single mutants to scy31 PKB3 double mutants. In contrast, complete loss of Scylla in a heteroallelic S6K combination does not rescue the S6K single mutant phenotype indicating that S6K is epistatic over scylla (Reiling, 2004).
Moreover, verexpression of scylla and charybdis not only suppresses the growth phenotype caused by over-activation of the Inr pathway in the eye but to a certain extent also rescues the lethality associated with the ubiquitous increase in Inr pathway activity due to either overexpression of PKB or loss of PTEN. scylla rescues the male-specific lethality caused by ubiquitous expression of PKB and organismal lethality associated with the partial but not complete loss of PTEN function. Similarly, PKB-associated male lethality is also rescued by charybdis overexpression. This indicates that scylla and charybdis have the capacity to act as potent negative regulators of insulin signaling downstream of PKB and PDK1 (Reiling, 2004).
Several lines of evidence suggest that Scylla and Charybdis act upstream of TSC and Rheb. Tsc1/2 mutant flies can be rescued to adulthood by reducing S6K signaling, and a mere reduction of one TOR copy in a Tsc1 mutant context results in a rescue to the pupal stage. Whether ubiquitous scylla overexpression could rescue the larval lethality of heteroallelic Tsc1/2 mutant combinations (Tsc12G3/Tsc1Q87X and Tsc256/Tsc2192) was examined using the da-Gal4 or Act5C-Gal4 drivers in combination with a UAS-scy transgene or EPscy at 18°C, 25°C, and 29°C. Ubiquitous overexpression of scylla/charybdis in a Tsc1/2 mutant background did in no case extend larval development beyond first/second instar, and these larvae died at the same time as Tsc1/2 mutants. Moreover, the big head phenotype of Tsc2192 (and Tsc256) induced by the eyflp/FRT system was not further enhanced in scyEP9.85 char180 Tsc2 triple-mutant heads. It has been shown that heads composed almost entirely of scylla charybdis double-mutant cells are enlarged. Conversely, GMRGal4-driven co-overexpression of Tsc1, Tsc2, and scylla or charybdis in the eye does not further reduce the small eye phenotype induced by coexpression of Tsc1 and Tsc2 on their own. The absence of an additive growth effect upon loss of Tsc2, scylla, and charybdis or overexpression of Tsc1/2 and scylla or charybdis suggests that they function in the same pathway. These results are consistent with the idea that Scylla and Charybdis act upstream of the TSC complex. This conclusion is further supported by the fact that neither a Rheb-dependent bulging eye phenotype nor organismal lethality could be suppressed by scylla/charybdis coexpression (Reiling, 2004).
Adini, I., et al. (2003). RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev. 17: 2721-2732. 14597666
Akagi, T., et al. (2000). v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc. Natl. Acad. Sci. 97: 7290-5.
Akiyama, H., et al. (2004). Interactions between Sox9 and ß-catenin control chondrocyte differentiation. Genes Dev. 18: 1072-1087. 15132997
Anderson, K. E., et al. (1998). PDGF-induced translocation of PDK-1 to the plasma membrane is important for its ability to activate PKB. Curr Biol 1998, 8: 684-69.
Andjelkovic, M., et al. (1995). Developmental regulation of expression and activity of multiple forms of the Drosophila RAC protein kinase. J. Biol. Chem. 270: 4066-4075
Andjelkovic, M., et al. (1997). Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272: 31515-31524.
Basu, S., et al. (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11: 11-23. 12535517
Bernal, A. and Kimbrell, D. A. (2000). Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity. Proc. Natl. Acad. Sci. 97(11): 6019-6024.
Biggs, W. H., et al. (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. 96(13): 7421-6.
Bouchard, C., Marquardt, J., Bras, A., Medema, R. H. and Eilers, M. (2004). Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 23(14):2830-40. 15241468
Brunet, A., et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
Cardone, M. H., et al. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282(5392): 1318-21. 9812896
Centanin, L., Ratcliffe, P. J. and Wappner, P. (2005). Reversion of lethality and growth defects in Fatiga oxygen-sensor mutant flies by loss of Hypoxia-Inducible Factor-alpha/Sima. EMBO Rep. 6(11): 1070-5. 16179946
Chen, H.-K., et al. (2003). Interaction of Akt-phosphorylated Ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113: 457-468. 12757707
Chen, W. S., et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev. 15: 2203-2208. 11544177
Chen, Y., Li, X., Eswarakumar, V. P., Seger, R. and Lonai, P. (2000). Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene 19: 3750-3756. 10949929
Cho, K. S., et al. (2001). Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway. Proc. Natl. Acad. Sci. 98: 6144-6149. 11344272
Chung, C. Y., Potikyan, G. and Firtel, R. A. (2001). Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa. Mol. Cell 7: 937-947. 11389841
Clancy, D. J., et al. (2001). Extension of life-span by loss of Chico, a Drosophila Insulin receptor substrate protein. Science 292: 104-6. 11292874
Cross, D. A., et al. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789. 8524413
Daly, C., et al. (2004). Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18: 1060-1071. 15132996
Dan, H. C., et al. (2002). Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277: 35364-35370. 12167664
Datta, S. R., et al. (1997). Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell 91: 231-241. 9346240
Dekanty, A., Lavista-Llanos, S., Irisarri, M., Oldham, S. and Wappner, P. (2005). The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima. J. Cell Sci. 118(Pt 23): 5431-41. 16278294
De Vita, G., et al. (2000). Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects. Cancer Res. 60: 3916-20.
del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. and Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689. 9381178
Di-Poï, N., et al. (2002). Antiapoptotic role of PPARß in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10: 721-733. 12419217
Dufner, A., et al. (1999). Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation. Mol. Cell. Biol. 19(6): 4525-34.
Enomoto, A., et al. (2005). Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev. Cell 9: 389-402. 16139227
Fornaro, M., et al. (2000). Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways. Mol. Biol. Cell. 11: 2235-49.
Frame, S., Cohen, P. and Biondi, R. M. (2001). A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7: 1321-1327. 11430833
Franke, T. F., Tartof, K. D. and Tsichlis, P. N. (1994). The SH2-like Akt homology (AH) domain of c-akt is present in multiple copies in the genome of vertebrate and invertebrate eucaryotes. Cloning and characterization of the Drosophila melanogaster c-akt homolog Dakt1. Oncogene 9(1): 141-8.
Dekanty, A., Lavista-Llanos, S., Irisarri, M., Oldham, S. and Wappner, P. (2005). The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima. J. Cell Sci. 118(Pt 23): 5431-41. 16278294
Frazier, M. R., Woods, H. A. and Harrison, J. F. (2001). Interactive effects of rearing temperature and oxygen on the development of Drosophila melanogaster. Physiol. Biochem. Zool. 74: 641-650. 11517449
Fujita, E., et al. (1999). Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem. Biophys. Res. Commun. 264: 550-555.
Garami, A., et al. (2003). Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11(6): 1457-66. 12820960
Gao, X., Neufeld, T. P. Pan, D. (2000). Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways. Dev. Biol. 221: 404-418.
Gao, X. and Pan, D. (2001). TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15: 1383-1392. 11390358
Genot, E. M., et al. (2000). The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase. Mol. Cell. Biol. 20: 5469-78.
Gingras, A.C., et al. (1998). 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12: 502-513.
Gottlob, K., et al. (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15: 1406-1418. 11390360
Guertin, D. A., et al. (2007). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCa, but not S6K1. Dev. Cell. 11: 859-871. Medline abstract: 17141160
Hakak, Y., Hsu, Y. S. and Martin, G. S. (2000). Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 19(28): 3164-71.
Hertweck, M., Göbel, C. and Baumeister, R., et al. (2004). C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev. Cell 6: 577-588. 15068796
Higuchi, M., et al. (2001). Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells. Curr. Biol. 11: 1958-1962. 11747822
Hill, M. M., Feng, J. and Hemmings, B. A. (2002). Identification of a plasma membrane raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12: 1251-1255. 12176337
Holland, E. C., et al. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25(1): 55-7.
Humbert, S., et al. (2002). The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell 2: 831-837. 12062094
Ingleyab, E. and Hemmingsa, B. A. (2000). PKB/Akt interacts with inosine-5' monophosphate dehydrogenase through its pleckstrin homology domain. FEBS Lett. 478(3): 253-259.
Inoki, K., Li, Y., Zhu, T., Wu, J. and Guan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4(9): 648-57. 12172553
Irvine, R. (1998). Translocation, translocation, translocation ... Curr. Biol. 8: R557-R559
Jiang, H., et al. (2005). Both the establishment and the maintenance of neuronal polarity require active mechanisms: Critical roles of GSK-3 and its upstream regulators. Cell 120: 123-135. 15652487
Jin, J., et al. (2001). Regulation of Drosophila tracheal system development by Protein kinase B. Dev. Cell 1: 817-827. 11740943
Jones, R. G., et al. (2000). Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191: 1721-34.
Jünger, M. A., Rintelen, F., Stocker, H., Wasserman, J. D., Vegh, M., Radimerski, T., Greenberg, M. E. and Hafen E. (2003). The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2: 20. 12908874
Kane, L. P., et al. (1999). Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol. 9: 601-604.
Kops, G. J., et al. (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634. 10217147
Kuruvilla, R., Ye, H. and Ginty, D. D. (2000). Spatially and functionally distinct roles of the PI3-K effector pathway during NGF signaling in sympathetic neurons. Neuron 27: 499-512.
Lawlor, M. A., et al. (2002). Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 21. 3728-3738. 12110585
Lee, J., et al. (2007). Akt mediates self-renewal division of mouse spermatogonial stem cells. Development 134: 1853-1859. Medline abstract: 17428826
Lee, J. W. and Juliano, R. L. (2000). alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol. Biol. Cell. 11: 1973-87.
Lee, J., et al. (2007). Akt mediates self-renewal division of mouse spermatogonial stem cells. Development 134(10): 1853-9. Medline abstract: 17428826
Lee, M.-J., et al. (2001). Akt-mediated phosphorylation of the G Protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Molec. Cell 8: 693-704. 11583630
Li, J., et al. (2005). Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of Integrin β1 to control cell migration. Dev. Cell 9: 663-673. 16256741
Li, X., Talts, U., Talts, J. F., Arman, E., Ekblom, P. and Lonai, P. (2001). Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane. Proc. Natl. Acad. Sci. 98: 14416-14421. 11734644
Lin, H.-K., et al. (2002). Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21: 4037-4048. 12145204
Lione, A. M., et al. (2000). Activation of extracellular signal-regulated kinase (ERK) and Akt by human Serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4. J. Neurochem. 75(3): 934-938
Liu, A. X., et al. (1998). AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58(14): 2973-7.
Liu, Y. and Lehmann, M. (2006). FOXO-independent suppression of programmed cell death by the PI3K/Akt signaling pathway in Drosophila. Dev. Genes Evol. [Epub ahead of print]. 16520939
Lynch, D. K. and Daly, R. J. (2002). PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21: 72-82. 11782427
Manning, B. D., et al. (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product Tuberin as a target of the Phosphoinositide 3-kinase/Akt pathway. Molec. Cell 10: 151-162. 12150915
Markus, A., Zhong, J. and Snider, W. D. (2002). Raf and Akt mediate distinct aspects of sensory axon growth. Neuron 35: 65-76. 12123609
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K. and Fukamizu, A. (2003). Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. 100(20): 11285-90. 13679577
Meili, R., Ellsworth, C. and Firtel, R. A. (2000). A novel Akt/PKB-related kinase is essential for morphogenesis in Dictyostelium. Curr. Biol. 10(12): 708-17.
Miron, M., et al. (2001). The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nat. Cell Bio. 3: 596-601. 11389445
Miron, M., Lasko, P. and Sonenberg, N. (2003). Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster. Mol. Cell. Biol. 23(24): 9117-26. 14645523
Mirza, A. M., et al. (2000). Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ. 11(6): 279-92.
Miyauchi, H., et al. (2004). Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23(1): 212-20. 14713953
Murga, C., Fukuhara, S. and Gutkind, J. S. (2000). A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt. J. Biol. Chem. 275: 12069-73.
Okumura, E., et al. (2002). Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat. Cell Biol. 4(2): 111-6. 11802161
Ozes, O. N., et al. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
Paradis, S. and Ruvkun, G. (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12: 2488-2498.
Peng, X.-d., et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17: 1352-1365. 12782654
Persad, S., et al. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis in PTEN null prostate cancer cells. Proc. Natl. Acad. Sci. 97: 3207-3212. 10716737
Persad, S., et al. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 276(29): 27462-9. 11313365
Plas, D. R. and Thompson, C. B. (2003). Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem. 278(14): 12361-6. 12517744
Potter, C. J., Huang, H. and Xu, T. (2001). Drosophila Tsc1 Functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105: 357-368. 11348592
Puig, O., Marr, M. T., Ruhf, R. L. and Tjian, R. (2003). Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes and Development 17: 2006-2020. 12893776
Quevedo, C., Kaplan, D. R. and Derry, W. B. (2007). AKT-1 regulates DNA-damage-induced germline apoptosis in C. elegans. Curr. Biol. 17(3): 286-92. Medline abstract: 17276923
Radimerski, T., Montagne, J., Rintelen, F., Stocker, H., van Der Kaay, J., Downes, C. P., Hafen, E., and Thomas, G. (2002a). dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat. Cell. Biol. 4: 251-255. 11862217
Radimerski, T., et al. (2002b). Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev. 16: 2627-2632. 12381661
Reiling, J. H. and Hafen, E. (2004). The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev. 18(23): 2879-92. 15545626
Rintelen, F., Stocker, H., Thomas, G. and Hafen, E. (2001). PDK1 regulates growth through Akt and S6K in Drosophila. Proc. Natl. Acad. Sci. 98: 15020-15025. 11752451
Romashkova, J. A. and Makarov, S. S. (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
Rommel, C., et al. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286: 1738-1741.
Schubert, K. M., Scheid, M. P. and Duronio, V. (2000). Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275(18): 13330-5.
Scott, P. H., et al. (1999). Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. 95: 7772-7777. 9636226
Sears, R., et al. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14: 2501-2514.
Sellers, L. A., et al. (2000). Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or akt pathways. Mol. Cell. Biol. 20: 5974-85.
Shioi, T., et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19: 2537-2548.
Shtivelman, E., Sussman, J. and Stokoe, D. (2002). A role for PI 3-Kinase and PKB activity in the G2/M phase of the cell cycle. Curr. Biol. 12: 919-924. 12062056
Staveley, B. E., et al. (1998). Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8(10): 599-602.
Stephens, L., et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714.
Stocker, H., Andjelkovic, M., Oldham, S., Laffargue, M., Wymann, M. P., Hemmings, B. A., and Hafen, E. (2002). Living with lethal PIP3 levels: Viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 295: 2088-2091. 11872800
Stokoe, D., et al. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277: 567-570.
Takaishi, H., et al. (1999). Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc. Natl. Acad. Sci. 96(21): 11836-41.
Takata, M. et al. (1999) Requirement for Akt (protein kinase B) in insulin-induced activation of glycogen synthase and phosphorylation of 4E-BP1 (PHAS-1). J. Biol. Chem. 274: 20611-20618.
Thomas, C. C., et al. (2002). High-resolution structure of the pleckstrin homology domain of Protein kinase B/akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr. Biol. 12: 1256-1262. 12176338
van Weeren, P. C., et al. (1998). Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273(21): 13150-6.
Verdu, J., Buratovich, M. A., Wilder, E. L. and Birnbaum, M. J. (1999). Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1: 500-506.
Vereshchagina, N. and Wilson, C. (2006). Cytoplasmic activated protein kinase Akt regulates lipid-droplet accumulation in Drosophila nurse cells. Development 133(23): 4731-5. Medline abstract: 17079271
Wang, X., et al. (2000). Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275: 14624-31.
Whitlock, B. B., et al. (2000). Differential roles for alphaMß2 integrin clustering or activation in the control of apoptosis via regulation of Akt and ERK survival mechanisms. J. Cell Bio. 151: 1305-1320. 11121444
Wong, B. R., et al. (1999). TRANCE, a TNF family member, activates Akt/PKB through a signalling complex involving TRAF6 and c-Src. Mol. Cell 4: 1041-1049.
Yang, J., et al. (2002). Molecular mechanism for the regulation of Protein kinase B/Akt by hydrophobic motif phosphorylation. Molec. Cell 9: 1227-1240. 12086620
Xie, P., et al. (2000). Activation of NF-kappa B by bradykinin through a Galpha q- and Gbeta gamma -dependent pathway that involves phosphoinositide 3-kinase and Akt. J. Biol. Chem. 275(32): 24907-24914.
Yano, H., et al. (2002). Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35: 697-709. 12194869
Zheng, D. Q., et al. (2000). Substrate specificity of alpha vbeta 3 integrin-mediated cell migration and phosphatidylinositol 3-Kinase/AKT pathway activation. J. Biol. Chem. 275(32): 24565-24574.
Zhou, H., et al. (2000). Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Bio. 151: 483-494. 11062251
Zimmermann, S. and Moelling, K. (1999). Phosphorylation and regulation of Raf by Akt (Protein kinase B). Science 286: 1741-1744.
date revised: 16 January 2008
Home page: The Interactive Fly © 1997 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.